Modest survival benefit with EBRT + brachytherapy in intermediate prostate cancer

A combination of external beam radiation therapy and brachytherapy provides a modest survival benefit compared with brachytherapy alone for patients with intermediate prostate cancer, a new study finds. The benefit is relatively small, so use of combined radiation therapy remains debatable in clinical practice, according to the investigators.

Renal & Urology News